Appendix 4C - Q2 FY22 Quarterly Cash Flow Report
Highlights: NZ’s regulator Medsafe authorizes Phase 2 clinical trial for ATH434; more jurisdictions to follow New poster presentation and publications...
Source: fnarena.com
Page 17 - Mouse Model News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mouse Model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mouse Model Today - Breaking & Trending Today
Protagonist Therapeutics Presents Updated Phase 2 Rusfertide Data in Polycythemia Vera (PV) at ASH 2021 Annual Meeting
/PRNewswire/ -- Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today presented updated data from two ongoing Phase 2 studies...
Source: prnewswire.com
Protagonist Therapeutics Presents Updated Phase 2 Rusfertide Data in Polycythemia Vera (PV) at ASH 2021 Annual Meeting
/PRNewswire/ -- Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today presented updated data from two ongoing Phase 2 studies...
Source: prnewswire.com
Zogenix To Present New FINTEPLA® (fenfluramine) Data at AES
Data add to the growing body of evidence supporting the efficacy and safety profile of FINTEPLA for the treatment of Dravet syndrome...
Source: globenewswire.com
FOXNEWS Hannity November 30, 2021 02:19:00
Everything. facts are stubborn things. here are the simple facts that dr. fauci needs to explain and the department of justice should investigate. on may 11th, dr. fauci testified before a senate committee that "the nih has not ever and does not now found the gain-of-function research in the wuhan institute of virology. that is a clear categorical statement. but then on october 20th, the nih wrote that they funded an experiment at the wuhan lab testing "if spiked proteins from naturally occurring bat coronavirus is circulating in china were capable of binding to the human a.c.e. to separator i...
Source: archive.org